Page last updated: 2024-11-05

thenoyltrifluoroacetone and Glioma

thenoyltrifluoroacetone has been researched along with Glioma in 1 studies

Thenoyltrifluoroacetone: Chelating agent and inhibitor of cellular respiration.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
McMillan-Ward, E1
Kong, J1
Israels, SJ1
Gibson, SB1

Other Studies

1 other study available for thenoyltrifluoroacetone and Glioma

ArticleYear
Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species.
    Journal of cell science, 2007, Dec-01, Volume: 120, Issue:Pt 23

    Topics: Autophagy; Cell Death; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Electron Transport Compl

2007